Search clinical trials for: Gilteritinib Fumarate
Total 1620 results
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedAdvanced Solid Tumors | Pharmacokinetics of 14C-labeled GilteritinibUnited States
-
Astellas Pharma IncCompleted
-
Astellas Pharma Global Development, Inc.CompletedAcute Myeloid Leukemia | Advanced Solid TumorsUnited States
-
Etan OrgelAstellas Pharma Global Development, Inc.No longer available
-
Astellas Pharma Global Development, Inc.CompletedRenal Impaired | Gilteritinib | Normal Renal Function | Pharmacokinetics of ASP2215United States, Bulgaria
-
Astellas Pharma Global Development, Inc.No longer availableAcute Myeloid Leukemia (AML) | FMS-like Tyrosine Kinase-3 (FLT3) MutationsAustralia, Italy, United Kingdom
-
Astellas Pharma Global Development, Inc.Approved for marketingAcute Myeloid Leukemia (AML) | FMS-like Tyrosine Kinase-3 (FLT3) MutationsUnited States, Canada, Japan
-
University of Rome Tor VergataActive, not recruiting
-
Astellas Pharma Global Development, Inc.National Heart, Lung, and Blood Institute (NHLBI); Blood and Marrow Transplant...CompletedAcute Myeloid LeukemiaUnited States, Japan, Korea, Republic of, Taiwan, Spain, Italy, United Kingdom, Australia, Belgium, Canada, Denmark, France, Germany, Greece, New Zealand, Poland
-
Astellas Pharma Korea, Inc.RecruitingAcute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) MutationKorea, Republic of
-
Guy's and St Thomas' NHS Foundation TrustKing's College LondonRecruiting
-
Erasca, Inc.WithdrawnAcute Myeloid LeukemiaUnited States
-
Astellas Pharma Global Development, Inc.CompletedAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) MutationUnited States
-
Astellas Pharma Global Development, Inc.Active, not recruitingAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) MutationUnited States, Japan, Taiwan, Spain, Australia, Belgium, Canada, France, Germany, Italy, Korea, Republic of, Poland, United Kingdom
-
AbbVieAstellas Pharma Inc; Genentech, Inc.CompletedAcute Myeloid Leukemia (AML)United States
-
Institute of Hematology & Blood Diseases Hospital...Not yet recruitingAML | Refractory | RelapsedChina
-
Swiss Federal Institute of TechnologyUniversity of Zurich; University Children's Hospital, Zurich; Jomo Kenyatta University...CompletedAnemia, Iron-deficiencyKenya
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.RecruitingAcute Myeloid Leukemia (AML)United States
-
AstraZenecaParexelCompletedChronic Obstructive Pulmonary Disease - COPDUnited States
-
Xi'an Xintong Pharmaceutical Research Co.,Ltd.Unknown
-
Oryzon Genomics S.A.RecruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryUnited States
-
AlbionSprim Advanced Life SciencesUnknown
-
Swiss Federal Institute of TechnologyCompletedIron-deficiencySwitzerland
-
University Health Network, TorontoActive, not recruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Relapsed Cancer | Refractory CancerCanada
-
BiogenCompletedHealthy VolunteersNew Zealand, Hong Kong
-
Merck Sharp & Dohme LLCWithdrawn
-
Banner Life Sciences LLCCompletedMultiple SclerosisUnited States
-
South Australian Health and Medical Research InstituteFlinders UniversityCompletedIron-deficiency | Anemia | Microbial ColonizationAustralia
-
Swiss Federal Institute of TechnologyBurgerstein VitamineCompletedIron-deficiencySwitzerland
-
Banner Life Sciences LLCCompletedRelapsing Remitting Multiple SclerosisUnited States
-
Prince of Songkla UniversityThe Thai Society of HematologyCompletedIron Deficiency AnemiaThailand
-
Astellas Pharma Global Development, Inc.CompletedAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) / Internal Tandem Duplication (ITD) MutationTaiwan, Poland, Serbia, United States, Brazil, Canada, Czechia, Denmark, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Portugal, Romania, Spain, Sweden, United Kingdom
-
BiogenTerminatedRelapsing Forms of MSIsrael
-
University of NebraskaNot yet recruitingPeripheral Arterial Disease | Peripheral Vascular Diseases | Peripheral Arterial Occlusive Disease | Peripheral Artery DiseaseUnited States
-
Nucorion Pharmaceuticals, Inc.Medpace, Inc.; Ligand PharmaceuticalsCompletedHepatitis BUnited States
-
Stichting Hemato-Oncologie voor Volwassenen NederlandAstellas Pharma Global Development, Inc.; Deutsch-Österreichische Studiengruppe...Active, not recruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2Netherlands, Belgium, Germany, Switzerland, Australia, Finland, Norway, Sweden, Austria, France, Ireland, Lithuania, Luxembourg, Spain
-
Isabelle Herter-AeberliBurgerstein VitamineCompletedLow Iron StoresSwitzerland
-
CelgeneAbbVieActive, not recruitingLeukemia, Myeloid, AcuteUnited States, Canada, France, United Kingdom, Belgium
-
Banner Life Sciences LLCEnrolling by invitationRelapsing Remitting Multiple SclerosisUnited States, Puerto Rico
-
National Institute on Drug Abuse (NIDA)University of MinnesotaCompleted
-
Thomas WalczykUnknownEffect of Iron Status on Occurrence of NTBISingapore
-
Xuanwu Hospital, BeijingTerminatedAcute Ischemic StrokeChina
-
BiogenCompletedMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingFrance
-
Sunnybrook Health Sciences CentreCompletedCervical Cancer | Anemia | Ovarian Cancer | Uterine CancerCanada
-
Almirall, S.A.Completed
-
BiogenCompleted
-
Astellas Pharma Global Development, Inc.Terminated
-
Isabelle Herter-AeberliBurgerstein VitamineCompletedIron-deficiencySwitzerland